Day One Biopharmaceuticals, Inc. ( NASDAQ:DAWN – Get Rating ) dropped 5% on Monday . The company traded as low as $12.98 and last traded at $13.00. Approximately 319,237 shares traded hands during mid-day trading, a decline of 57% from the average daily volume of 742,813 shares. The stock had previously closed at $13.68. Analysts Set New Price Targets A number of equities research analysts recently issued reports on the company. Oppenheimer assumed coverage on Day One Biopharmaceuticals in a research report on Thursday, February 2nd.

https://www.dailypolitical.com/2023/05/10/day-one-biopharmaceuticals-nasdaqdawn-shares-down-5.html

#dailypolitical